Consumer advocacy groups have warned for months that Charter’s proposed merger with Time Warner Cable and Bright House Networks could harm online video distributors.
Today, the leaders of the Senate antitrust committee are raising the same concern.
“We urge you to closely review these transactions to ensure that they do not impede new, developing options for consumers to receive video content,” Sens. Mike Lee (R-Utah) and Amy Klobuchar (D-Minnesota), write today to the Federal Communications Commission and Justice Department. Lee chairs the Senate antitrust committee, while Klobuchar serves as ranking member.
The letter repeats assertions by merger opponents that Charter and Comcast together will control between 70 and 90 percent of broadband connections faster than 25 Mbps in the U.S.
“Some worry,” the lawmakers write, “that such a dominant position would allow the two companies, without overtly colluding, to undermine the ability of online video distributors to offer a viable alternative to cable services.”
Charter has said it has no motive to hinder online video distributors because Web video is sparking consumers’ demand for high-speed broadband. The company also has promised to follow net neutrality rules for three years post-merger, and to avoid imposing data caps or usage-based billing for three years.
Full content: Media Post
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas